Search research articles
Contact Us
Filters
Showing results (231-240 of 250) with videos related to
Page
of 25
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2018
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis
Devyani Deshpande, Jotam G Pasipanodya, Stellah G Mpagama, et al.
Antimicrobial Agents and Chemotherapy
|
November 5, 2014
Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections
Sujata M Bhavnani, Jeffrey P Hammel, Scott A Van Wart, et al.
Antimicrobial Agents and Chemotherapy
|
September 28, 2023
Impact of antibiotic pharmacokinetics in urine on recurrent bacteriuria following treatment of complicated urinary tract infections
David Melnick, Angela K Talley, Vipul K Gupta, et al.
Antimicrobial Agents and Chemotherapy
|
May 15, 2013
Pharmacokinetic-pharmacodynamic determinants of oseltamivir efficacy using data from phase 2 inoculation studies
C R Rayner, C C Bulik, M A Kamal, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
January 8, 2022
4-PBA Treatment Improves Bone Phenotypes in the Aga2 Mouse Model of Osteogenesis Imperfecta
Ivan Duran, Jennifer Zieba, Fabiana Csukasi, et al.
Open Forum Infectious Diseases
|
November 28, 2025
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>: Brief Summary
Sujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 2013
Pharmacokinetics-pharmacodynamics of tazobactam in combination with ceftolozane in an in vitro infection model
Brian VanScoy, Rodrigo E Mendes, Anthony M Nicasio, et al.
Open Forum Infectious Diseases
|
November 28, 2025
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>
Sujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, et al.
Antimicrobial Agents and Chemotherapy
|
January 21, 2016
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model
Anthony M Nicasio, Brian D VanScoy, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
March 22, 2023
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 250) with videos related to
Sort By:
Page
of 25
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 30, 2018
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis
Devyani Deshpande, Jotam G Pasipanodya, Stellah G Mpagama, et al.
Antimicrobial Agents and Chemotherapy
|
November 5, 2014
Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections
Sujata M Bhavnani, Jeffrey P Hammel, Scott A Van Wart, et al.
Antimicrobial Agents and Chemotherapy
|
September 28, 2023
Impact of antibiotic pharmacokinetics in urine on recurrent bacteriuria following treatment of complicated urinary tract infections
David Melnick, Angela K Talley, Vipul K Gupta, et al.
Antimicrobial Agents and Chemotherapy
|
May 15, 2013
Pharmacokinetic-pharmacodynamic determinants of oseltamivir efficacy using data from phase 2 inoculation studies
C R Rayner, C C Bulik, M A Kamal, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
January 8, 2022
4-PBA Treatment Improves Bone Phenotypes in the Aga2 Mouse Model of Osteogenesis Imperfecta
Ivan Duran, Jennifer Zieba, Fabiana Csukasi, et al.
Open Forum Infectious Diseases
|
November 28, 2025
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>: Brief Summary
Sujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, et al.
Antimicrobial Agents and Chemotherapy
|
May 1, 2013
Pharmacokinetics-pharmacodynamics of tazobactam in combination with ceftolozane in an in vitro infection model
Brian VanScoy, Rodrigo E Mendes, Anthony M Nicasio, et al.
Open Forum Infectious Diseases
|
November 28, 2025
Evaluation of Aminoglycoside Dosing Regimens Adjusted for Renal Function and In Vitro Susceptibility Test Interpretive Criteria for Enterobacterales and <i>Pseudomonas aeruginosa</i>
Sujata M Bhavnani, Jeffrey P Hammel, Nikolas J Onufrak, et al.
Antimicrobial Agents and Chemotherapy
|
January 21, 2016
Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model
Anthony M Nicasio, Brian D VanScoy, Rodrigo E Mendes, et al.
Antimicrobial Agents and Chemotherapy
|
March 22, 2023
Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae
Sujata M Bhavnani, Jeffrey P Hammel, Elizabeth A Lakota, et al.
Page
of 25